NCT00290914View on ClinicalTrials.gov

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Major Depressive Disorder
Interventions
DRUG

Vilazodone

Sponsors
All Listed Sponsors
lead

Pharmacology Research Institute

OTHER

NCT00290914 - Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter